Skip to content
The GLP-1 Verdict
Menu
Ranked #202 · Grade C

Willow review

Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Visit Willow Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $299/mo (starting dose, compounded)
Tirzepatide
From $399/mo (starting dose, compounded)
Coverage
Not disclosed
Brand-name
Compounded only

The scorecard

Willow scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty64/100
Prescriber access57/100
Formulary choice88/100
Cancellation fairness56/100
Member support70/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Ranked #202 of 499 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. On the board it sits between Velvet Rx, 68/100 above and Belle Health at 67/100 below, with the ARSYNL Rx ruling the next one down.

Weighing it against something else? Every provider we would put in front of Willow is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Willow goes to CoreAge Rx, 94/100 to 68/100.

Visit Willow

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Willow's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Willow's site. Not medical advice; see our disclosure.

← Back to all rankings